Supn stock zacks
Supernus Pharm stocks price quote with latest real-time prices, charts, SUPN : 23.61 (-2.64%) Zacks Equity Research - ZACKS - Tue Nov 5, 5:45PM CST. The latest closing stock price for Supernus Pharmaceuticals as of January 10, 2020 is 24.25. The all-time high Supernus last 52 weeks is 30.94. Compare SUPN With Other Stocks Fundamental data from Zacks Investment Research, Inc. Supernus Pharmaceuticals Market Cap 2011-2019 | SUPN Compare SUPN With Other Stocks Fundamental data from Zacks Investment Research, Inc. SUPN, Supernus Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Zacks Equity Research 11/05/2019 12:45 PM ET Supernus Pharmaceuticals (SUPN) Jumps: Stock Rises 6.2% By Zacks Investment Research - Jun 01, 2017. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
14/08/2019 · Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
SUPN: Get the latest Supernus Pharmaceuticals stock price and detailed Zacks 71d. Supernus Announces Third Quarter 2019 Financial Results and Topline Supernus Pharm stocks price quote with latest real-time prices, charts, SUPN : 23.61 (-2.64%) Zacks Equity Research - ZACKS - Tue Nov 5, 5:45PM CST. The latest closing stock price for Supernus Pharmaceuticals as of January 10, 2020 is 24.25. The all-time high Supernus last 52 weeks is 30.94. Compare SUPN With Other Stocks Fundamental data from Zacks Investment Research, Inc. Supernus Pharmaceuticals Market Cap 2011-2019 | SUPN Compare SUPN With Other Stocks Fundamental data from Zacks Investment Research, Inc.
SUPERNUS PHARMACEUTICALS Income Statement, Balance Sheet and Statement of Cash Flows. SUPERNUS PHARMACEUTICALS Performance Chart, charts, historical data, comparisons and more at Zacks Advisor Tools.
View Supernus Pharmaceuticals, Inc. SUPN investment & stock information. Get the latest Supernus Pharmaceuticals, Inc. SUPN detailed stock quotes, stock Zacks' proprietary data indicates that Supernus Pharmaceuticals, Inc. is currently rated as a Zacks Rank 3 and we are looking for an inline return from the SUPN
30/12/2019 · Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingDec 2019 , …
Zacks' proprietary data indicates that Supernus Pharmaceuticals, Inc. is currently rated as a Zacks Rank 3 and we are looking for an inline return from the SUPN View SUPN's stock price, price target, earnings, financials, forecast, insider According to Zacks Investment Research, "Supernus Pharmaceuticals Inc. is a Get breaking news and analysis on Supernus Pharmaceuticals, Inc. (SUPN) stock, price quote and chart, trading and investing at Zacks.com (Nov 5, 2019). Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Earnings Report Date | Our vendor, Zacks Investment Research, might revise this date in the future, 5 Nov 2019 Supernus, which belongs to the Zacks Medical - Generic Drugs industry, Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report Find the latest Supernus Pharmaceuticals, Inc. (SUPN) stock quote, history, news and other vital information to help you with your stock Zacks•2 months ago 5 Nov 2019 Supernus (SUPN) delivered earnings and revenue surprises of -8.47% the current status translates into a Zacks Rank #3 (Hold) for the stock.
Already reeling from a tumbling stock price, Fluidigm (NASDAQ: FLDM) out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate.
View detailed financial information, real-time news, videos, quotes and analysis on Supernus Pharmaceuticals Inc. (NASDAQ:SUPN). Explore commentary on Supernus Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about SUPN. 29/10/2019 · Supernus doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Click to get this free report Supernus Pharmaceuticals, Inc. (SUPN): Free Stock Analysis Report To read this article on Zacks.com click here. Stock quote for Supernus Pharmaceuticals, Inc. Common Stock Common Stock (SUPN) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
5 Jan 2020 4 Insurance Stocks for Your Investment Portfolio in 2020. Zacks CHK, FCEL, SUPN and PAYS among midday movers. SeekingAlpha Top trades and best-performing strategies with AMC Entertainment Holdings, Inc. $AMC supported by the most actionable news from the market. Already reeling from a tumbling stock price, Fluidigm (NASDAQ: FLDM) out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. 6 days ago One research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and three have given a buy 30 Dec 2019 According to Zacks, analysts expect that Supernus Pharmaceuticals Shares of SUPN stock traded down $0.16 during trading on Tuesday, 8 Jan 2020 The stock EPS is $-1.33 against its recent stock value of $168.5 per share. First we Currently, the ATR value of company's stock is situated at 3.9. Supernus Pharmaceuticals (SUPN) Stock, Few Things Worth Considering